Howard A. "Skip" Burris, III, MD, FACP, FASCO, president, clinical operations, and chief medical officer of Sarah Cannon Research Institute, discusses what's needed from a policy perspective to ensure access to next-generation sequencing (NGS) tests.
Howard A. "Skip" Burris, III, MD, FACP, FASCO, president, clinical operations, and chief medical officer of Sarah Cannon Research Institute, discusses what's needed from a policy perspective to ensure access to next-generation sequencing tests.
Transcript
As next-generation testing becomes more important with a growing amount of approved targeted therapies, what is needed from a policy perspective to ensure access to these tests?
Access to these tests and getting the various stakeholders together. if I were a payer at an insurance company, my question wouldn’t be whether I approve the testing or not, it would really be how could you be prescribing this new therapy, this relatively expensive therapy, without having a molecular profile on the patient. I think much like we’ve had legislation with regard to access to clinical trials, this sort of national education that cancer patients should be access agnostic to being able to getting a test performed, would be key.
A good first step has been the FDA approving some of these tests and then Medicare providing reimbursement. So, I feel optimistic that were moving in a direction where we’re going to begin to get policy makers across the country, the physicians across the country, to understand this is a critical piece of information cancer patients should know.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen